Beneficial effects of circulating progenitor endothelial cells activated by angiotensin receptor antagonists

Hypertension

Volumn 45, Issue 4, 2005, Pages 491-492

  Levy, Bernard I ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; VALSARTAN;

CELL ACTIVATION; CELL AGING; CELL COUNT; CELL PROLIFERATION; DRUG DOSE REGIMEN; DRUG MECHANISM; EDITORIAL; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; HEART MUSCLE ISCHEMIA; HUMAN; HYPERTENSION; NEOVASCULARIZATION (PATHOLOGY); NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; STEM CELL;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELL COUNT; DIABETES MELLITUS, TYPE 2; ENDOTHELIAL CELLS; HEMATOPOIETIC STEM CELLS; HUMANS;

EID: 15744363220     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.0000159196.10515.b5     Document Type: Editorial

References (10)

1. Bahlmann FH, de Groot K, Mueller OH, Hertel B, Haller H, Fliser D. Stimulation of endothelial progenitor cells-a new putative therapeutic effect of angiotensin II receptor antagonists. Hypertension. 2005;45:526-529.
2. Asahara T, Murohara T, Sullivan A, Silver M, van der Zee R, Li T, Witzenbichler B, Schatteman G, Isner JM. Isolation of putative progenitor endothelial cells for angiogenesis. Science. 1997;275:964-967.
3. Vasa M, Fichtlscherer S, Aicher A, Adler K, Urbich C, Martin H, Zeiher AM, Dimmeler S. Number and migratory activity of circulating endothelial progenitor cells inversely correlate with risk factors for coronary artery disease. Circ Res. 2001;89:E1-E7.
4. Tamarat R, Silvestre JS, Le Ricousse-Roussanne S, Barateau V, Lecomte-Raclet L, Clergue M, Duriez M, Tobelem G, Levy BI. Impairment in ischemia-induced neovascularization in diabetes: bone marrow mononuclear cell dysfunction and therapeutic potential of placenta growth factor treatment. Am J Pathol. 2004;164:457-466.
5. Dimmeler S, Aicher A, Vasa M, Mildner-Rihm C, Adler K, Tiemann M, Rutten H, Fichtischerer S, Martin H, Zeiher AM. 3hydroxy3methylglutaryl (HMG)-coenzymeA (CoA) reductase inhibitors (statins) increase endothelial progenitor cells via the PI 3-kinase/Akt pathway. J Clin Invest. 2001;108:391-397.
6. Walter DH, Zeiher AM, Dimmeler S. Effects of statins on endothelium and their contribution to neovascularization by mobilization of endothelial progenitor cells. Coron Artery Dis. 2004;15:235-242.
7. Sowers JR. Hypertension, Angiotensin II, and Oxidative Stress. N Engl J Med. 2002;346:1999-2001.
8. Wolin MS. Interactions of oxidants with vascular signaling systems. Arterioscler Thromb Vasc Biol. 2000;20:1430-1442.
9. Rueckschloss U, Quinn MT, Hotz J, Morawietz H. Dose-dependent regulation of NAD(P)H oxidase expression by angiotensin II in human endothelial cells. Protective effect of angiotensin II type 1 receptor blockade in patients with coronary artery disease. Arterioscler Thromb Vasc Biol. 2002;22:1845-1851.
10. Imanishi T, Hano T, Nishio I. Angiotensin II accelerates endothelial progenitor cell senescence through induction of oxidative stress. J Hypertens. 2005;23:97-104.